Assurity
Vendor:
First CVE: Apr 25, 2018 · Active for 8 years
2
Total CVEs
More Total CVEs than 49% of tracked products
2.0
Avg CVEs / Year
Higher CVE frequency than 60% of tracked products
7.7
Avg CVSS
Higher Avg CVSS than 61% of tracked products
0.0%
KEV Rate
Bottom 1%
Trends Over Time
The number and severity of CVEs published that impact Assurity over time
Volume of CVEsAvg CVSS Base Score
First CVE
Apr 25, 2018
8 years ago
Most Recent CVE
Apr 25, 2018
3,012 days ago
CVE Severity & Scoring
Assurity2 CVEs
50%
50%
All CVEs352,231 CVEs
45%
40%
11%
MediumHigh
Attack Vector
Local0 (0.0%)
Network0 (0.0%)
Unknown0 (0.0%)
Physical0 (0.0%)
Adjacent Network2 (100.0%)
Attack Complexity
Low2 (100.0%)
High0 (0.0%)
Unknown0 (0.0%)
User Interaction
None2 (100.0%)
Unknown0 (0.0%)
Required0 (0.0%)
Privileges Required
Low0 (0.0%)
High0 (0.0%)
None2 (100.0%)
Unknown0 (0.0%)
Top CVEs
Signals from CVEs in this product scope (2 CVEs).
2 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2017-12712HIGH The authentication algorithm in Abbott Laboratories pacemakers manufactured prior to Aug 28, 2017, which involves an authentication key and time stamp, can be compromised or bypass | Apr 25, 2018 | 8.8 | 28 | NO | NO |
CVE-2017-12714MEDIUM Abbott Laboratories pacemakers manufactured prior to Aug 28, 2017 do not restrict or limit the number of correctly formatted "RF wake-up" commands that can be received, which may a | Apr 25, 2018 | 6.5 | 17 | NO | NO |
Exploit Exposure
Signals from CVEs in this product scope (2 CVEs).
CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%
Social Chatter
Signals from CVEs in this product scope (2 CVEs).
Media Mentions
Signals from CVEs in this product scope (2 CVEs).
Top CNAs Publishing CVEs For Assurity
Top CWEs
Versions
No cataloged versions.